References
- Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 1991;79:428–437.
- Bittencourt AL, da Gracas Vieira M, Brites CR, et al. Adult T-cell leukemia/lymphoma in Bahia, Brazil: analysis of prognostic factors in a group of 70 patients. Am J Clin Pathol 2007;128:875–882.
- Uchida T, Kinoshita T, Watanabe T, et al. The CDKN2 gene alterations in various types of adult T-cell leukaemia. Br J Haematol 1996;94:665–670.
- Tawara M, Hogerzeil SJ, Yamada Y, et al. Impact of p53 aberration on the progression of Adult T-cell Leukemia/Lymphoma. Cancer Lett 2006;234:249–255.
- Furukawa Y, Tara M, Izumo S, et al. HTLV-I viral escape and host genetic changes in the development of adult T cell leukemia. Int J Cancer 2006;118:381–387.
- Sakashita A, Hattori T, Miller CW, et al. Mutations of the p53 gene in adult T-cell leukemia. Blood 1992;79:477–480.
- Nagai H, Kinoshita T, Imamura J, et al. Genetic alteration of p53 in some patients with adult T-cell leukemia. Jpn J Cancer Res, 1991;82:1421–1427.
- Sugito S, Yamato K, Sameshima Y, et al. Adult T-cell leukemia: structures and expression of the p53 gene. Int J Cancer 1991;49:880–885.
- Yamada Y, Hatta Y, Murata K, et al. Deletions of p15 and/or p16 genes as a poor-prognosis factor in adult T-cell leukemia. J Clin Oncol 1997;15:1778–1785.
- Nishimura S, Asou N, Suzushima H, et al. p53 gene mutation and loss of heterozygosity are associated with increased risk of disease progression in adult T cell leukemia. Leukemia 1995;9:598–604.
- Kato S, Han SY, Liu W, et al. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc Natl Acad Sci USA 2003;100:8424–8429.
- Cao H, Jiang Y, Wang Y. Kinetics of deamination and Cu(II)/H2O2/Ascorbate-induced formation of 5-methylcytosine glycol at CpG sites in duplex DNA. Nucleic Acids Res 2009;37:6635–6643.
- Sato H, Oka T, Shinnou Y, et al. Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia/lymphoma. Am J Pathol 2010;176:402–415.
- Cairns P, Mao L, Merlo A, et al. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 1994;265:415–417.
- Kinpara S, Kijiyama M, Takamori A, et al. IFN-a suppresses HTLV-1 expression via PKR in infected cells and renders them susceptible to AZT through p53 activation in AZT/IFN-a treatment. Retrovirol 2014;11(Suppl. 1):O24.